A detailed history of David J Yvars Group transactions in Neuronetics, Inc. stock. As of the latest transaction made, David J Yvars Group holds 31,500 shares of STIM stock, worth $43,785. This represents 0.01% of its overall portfolio holdings.

Number of Shares
31,500
Previous 66,500 52.63%
Holding current value
$43,785
Previous $119,000 80.67%
% of portfolio
0.01%
Previous 0.08%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$0.73 - $2.0 $25,550 - $70,000
-35,000 Reduced 52.63%
31,500 $23,000
Q2 2024

Jul 22, 2024

SELL
$1.73 - $4.81 $5,570 - $15,488
-3,220 Reduced 4.62%
66,500 $119,000
Q1 2024

Apr 11, 2024

SELL
$2.68 - $4.8 $13,962 - $25,008
-5,210 Reduced 6.95%
69,720 $331,000
Q4 2023

Jan 09, 2024

BUY
$1.05 - $2.9 $40,876 - $112,897
38,930 Added 108.14%
74,930 $217,000
Q3 2023

Oct 13, 2023

BUY
$1.29 - $2.22 $4,515 - $7,770
3,500 Added 10.77%
36,000 $48,000
Q2 2023

Jul 10, 2023

BUY
$2.07 - $2.92 $34,879 - $49,202
16,850 Added 107.67%
32,500 $69,000
Q1 2023

Apr 19, 2023

SELL
$2.81 - $6.71 $61,173 - $146,076
-21,770 Reduced 58.18%
15,650 $45,000
Q4 2022

Jan 17, 2023

BUY
$2.74 - $6.87 $32,332 - $81,066
11,800 Added 46.06%
37,420 $0
Q3 2022

Oct 26, 2022

BUY
$2.35 - $4.66 $23,500 - $46,600
10,000 Added 64.02%
25,620 $81,000
Q2 2022

Jul 15, 2022

BUY
$2.09 - $3.71 $11,484 - $20,386
5,495 Added 54.27%
15,620 $50,000
Q1 2022

Apr 21, 2022

SELL
$2.84 - $4.52 $42,245 - $67,235
-14,875 Reduced 59.5%
10,125 $31,000
Q4 2021

Jan 18, 2022

BUY
$3.87 - $6.59 $96,750 - $164,750
25,000 New
25,000 $27,000
Q3 2021

Oct 18, 2021

SELL
$6.22 - $15.54 $203,642 - $508,779
-32,740 Closed
0 $0
Q2 2021

Jul 21, 2021

BUY
$10.15 - $17.25 $132,051 - $224,422
13,010 Added 65.94%
32,740 $524,000
Q1 2021

Apr 19, 2021

SELL
$10.6 - $21.27 $337,345 - $676,917
-31,825 Reduced 61.73%
19,730 $244,000
Q4 2020

Jan 20, 2021

BUY
$4.95 - $11.45 $255,197 - $590,304
51,555 New
51,555 $573,000

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $37.6M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track David J Yvars Group Portfolio

Follow David J Yvars Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of David J Yvars Group, based on Form 13F filings with the SEC.

News

Stay updated on David J Yvars Group with notifications on news.